Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Alan Wookey
Scientific Advisor, Oncology and Companion Diagnostics
Prior to joining Q2 Solutions, Alan Wookey served as Director and Head of the Oncology Biomarker Group at AstraZeneca where he initiated the company’s personalized medicine and pharmacogenetics efforts, as well as their Clinical Biomarkers Group. During his more than 20-year career, Wookey also served as Associate Vice President, Global Head of Companion Diagnostics, of LabCorp Clinical Trials (now Covance). 

At Q2 Solutions, he leads business development and scientific strategy for the companion diagnostics and oncology service offerings. He also provides expert consultation in a number of areas including science and technologies, regulatory and management.  Alan Wookey earned Bachelor of Science (B.Sc.) degrees in life sciences and microbiology from the University of Liverpool and his Post Graduate Diploma in Management Studies from Manchester Metropolitan University.

Related Services: